A new drug to potentially treat depression and neurodegenerative diseases, such as dementia or Parkinson’s, is being ...

Alzheimer's disease is the most common type of dementia. Here, we break down what to know about this disease, including: What ...

However, a recent study from Sunnybrook Research Institute offers some hope. Researchers found that a type of diabetes ...

As the second oral therapy approved by the U.S. Food and Drug Administration (FDA) for the treatment of Alzheimer’s disease during the past decade, ZUNVEYL demonstrates a potentially better safety ...

Namenda (memantine) is a prescription drug that’s used to treat dementia related to Alzheimer’s disease. This drug can interact with other medications and some supplements. For example ...

Dr. Jeanne Wei, triple board-certified M.D. and Ph.D., Chair, Reynolds Department of Geriatrics & Executive Director of the Reynolds Institute on Aging (RIOA), gives Nichole an in-depth review of the ...

Zunveyl, an oral medication, is a better-tolerated version of galantamine for managing mild to moderate Alzheimer's symptoms.

(“Alpha”) of the improved new drug ZUNVEYL（benzgalantamine delayed-release tablets）(“ZUNVEY” or the “Product”) for the treatment of mild-to-moderate dementia of the Alzheimer’s ty ...

Medical advances make pills to treat Alzheimer’s disease viable, though challenges remain in sharing gains globally ...

(“Alpha”) of the improved new drug ZUNVEYL (benzgalantamine delayed-release tablets ) (“ZUNVEY” or the “Product”) for the treatment of mild-to-moderate dementia of the Alzheimer’s type. The Group is ...